Greenstone launched the generic equivalent of Pristiq® (desvenlafaxine succinate). The Greenstone items will be added to the OneStop program in the A-slot position with visibility in McKesson Connect tomorrow, Thursday, March 2, 2017.
Estimated U.S. brand sales of Pristiq® are $820M.
There will be ASAP and ASAP+ for this launch. Product is expected to arrive to stores starting Friday, March 3, 2017.
Brand Items:
| Item # |
NDC |
Description |
| 1315944 |
0008121130 |
PRISTIQ TAB 50MG 30 |
| 1316488 |
0008121101 |
PRISTIQ TAB 50MG 90 |
| 1317205 |
0008122230 |
PRISTIQ TAB 100MG 30 |
| 1317221 |
0008122201 |
PRISTIQ TAB 100MG 90 |
| 3438959 |
0008121030 |
PRISTIQ TAB 25MG 30 |
| Product launch information — OneStop® add |
| Bx Name |
Pristiq® |
| Bx Supplier |
Pfizer Inc. |
| Generic Name |
desvenlafaxine succinate |
| Generic Description |
desvenlaf suc or desvenlafax ER |
| Launch Reason |
FDA Approval |
| FDA Launch Exclusivity |
181 days of exclusivity granted to 10 suppliers |
| Number of Players |
5 at this time |
| U.S. Brand Sales |
$820M |
| Therapeutic Class / Indication: |
281604-ANTIDEPRESSANTS/ indicated for the treatment of major depressive disorder (MDD) |
To order, please use the following item numbers:
| Item # |
Supplier Name |
NDC |
Description |
OS Add |
| 3625373 |
Greenstone Limited |
59762121103 |
DESVENLAF SU ER TB 50MG GRE30 |
03/02/2017 |
| 3625332 |
Greenstone Limited |
59762122203 |
DESVENLAF SUC ER TB 100MGGRE30 |
03/02/2017 |
| 3625324 |
Greenstone Limited |
59762121003 |
DESVENLAF SUC ER TB 25MG GRE30 |
03/02/2017 |
For questions, please contact ISManagement@McKesson.com.